Latest Updates




SOCMA Providing Real-Time Intelligence, Resources in Response to COVID-19

As specialty and fine chemical manufacturers continue to stand on the frontlines, providing valuable and life-sustaining products during this unprecedented time, the Society of Chemical Manufacturers and Affiliates (SOCMA) is providing valuable intelligence and resources to help its members and industry navigate the challenges of the COVID-19 pandemic.

April 3, 2020


SOCMA Seeks Member Input on Chinese-origin Medical-Care Products

The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.

March 31, 2020


OSHA Regulations and COVID-19

The following guidance addresses OSHA health and safety regulatory requirements related to the current COVID-19 pandemic.

March 24, 2020



TSCA CBI Substantion

The U.S. Environmental Protection Agency has finalized its procedural rule for the review of TSCA CBI claims. This guidance document outlines and addresses the substantiation requirements for manufacturers and processors who seek to maintain CBI claims for specific chemical identities listed on the confidential portion of the TSCA Inventory.

March 18, 2020